Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Padivax
- Development stage
- Preclinical
- Lead developer
- POP Biotechnologies
- Modality
- Vaccines & Immunotherapeutics, Peptides, Nanoparticles → Drug Delivery Systems
01
Overview
Padivax is an experimental pentavalent peptide vaccine being developed by POP Biotechnologies in partnership with EuBiologics (through their joint venture EuPOP Life Sciences) for the treatment of Alzheimer's disease. The vaccine utilizes POP Biotechnologies' proprietary SNAP (spontaneous nanoliposome antigen particle) platform, which involves porphyrin-phospholipid (PoP) liposomes that display multiple peptide antigens in a mosaic-like fashion. Padivax is designed to simultaneously target multiple epitopes of both amyloid-beta (Aβ) and hyperphosphorylated tau proteins, the two primary pathological hallmarks of Alzheimer's. This dual-targeting approach aims to generate a robust polyclonal antibody response to clear Aβ plaques and tau neurofibrillary tangles, potentially slowing cognitive decline and improving cognitive function.
- Brand names
- PADIVAX
- Other names
- Alzheimer's/Padivax
02
Targets
Aβ (Amyloid-beta peptides and aggregates)MAPT (Microtubule-associated protein tau)
Beyond the preview
Go deeper on Padivax.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Padivax.